Hematologic Cancer Clinical Trial
Official title:
Hypnosis: a Path to Appeasement
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04966156 -
Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT
|
N/A | |
| Recruiting |
NCT05715047 -
Intervention for Fatigue in HCT Recipients
|
N/A | |
| Recruiting |
NCT05142033 -
Avera Cancer Sequencing and Analytics Protocol (ASAP)
|
||
| Completed |
NCT06053918 -
Research-Action in Hematology From Hospitalization to Home
|
||
| Recruiting |
NCT05175508 -
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04822974 -
TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS
|
N/A | |
| Not yet recruiting |
NCT06279585 -
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
|
N/A | |
| Recruiting |
NCT05753501 -
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
|
Phase 1 | |
| Recruiting |
NCT05481502 -
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
|
N/A | |
| Not yet recruiting |
NCT04412135 -
The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality
|
||
| Not yet recruiting |
NCT06377059 -
Early Detection of Complications During Immunotherapy for Haematological Malignancy
|
N/A | |
| Completed |
NCT04235153 -
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
|
||
| Recruiting |
NCT05626764 -
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management
|
||
| Active, not recruiting |
NCT04035447 -
Symptom Management for YA Cancer Survivors
|
N/A | |
| Not yet recruiting |
NCT05602168 -
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
|
N/A | |
| Terminated |
NCT03955276 -
An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)
|
||
| Recruiting |
NCT03091933 -
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT01792882 -
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
|
||
| Active, not recruiting |
NCT05493800 -
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
|
Phase 2 | |
| Active, not recruiting |
NCT05690230 -
Improving Patient Experience: BMBA
|
N/A |